List of Tables
Summary Table: Global Market for Wound Care Biologics, by Region, Through 2030
Table 1: ECM Components and Their Role in Wound Healing
Table 2: Number and Distribution of Persons Age 60+, by Region, 2019 and 2050
Table 3: Global Prevalence of Diabetes, by Population Segment, Through 2045
Table 4: Recent Industry Collaborations in Wound Care Biologics Market, 2024-2025
Table 5: Emerging Nanotherapeutic Approaches for Wound Healing Applications
Table 6: Emerging Bioprinting Methods for Wound Healing Applications
Table 7: Global Market for Wound Care Biologics, by Product Type, Through 2030
Table 8: Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 9: Global Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 10: Global Market for Wound Care Biologics for Acellular CTPs, by Region, Through 2030
Table 11: Global Market for Wound Care Biologics for Cellular CTPs, by Region, Through 2030
Table 12: Global Market for Wound Care Biologics for Biologic Skin Substitutes, by Region, Through 2030
Table 13: Global Market for Wound Care Biologics for Biologic Skin Substitute, by Tissue Source, Through 2030
Table 14: Placental Allograft Products
Table 15: Global Market for Wound Care Biologics for Allografts, by Region, Through 2030
Table 16: Acellular Animal-Derived Tissue-Based Products/Xenografts
Table 17: Global Market for Wound Care Biologics for Xenografts, by Region, Through 2030
Table 18: Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Composition, Through 2030
Table 19: Global Market for Wound Care Biologics for Bioengineered Skin Substitute, by Region, Through 2030
Table 20: Human Cellular Bioengineered Skin Substitutes
Table 21: Global Market for Wound Care Biologics for Cellular Bioengineered Skin Substitute, by Region, Through 2030
Table 22: Biosynthetic Skin Substitutes
Table 23: Global Market for Wound Care Biologics for Acellular Bioengineered Skin Substitute, by Region, Through 2030
Table 24: Global Market for Wound Care Biologics for Topical Agents, by Region, Through 2030
Table 25: Examples of Commercially Available Topical Agents
Table 26: Global Market for Wound Care Biologics, by Application, Through 2030
Table 27: Global Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 28: Global Market for Wound Care Biologics for Chronic Wounds, by Region, Through 2030
Table 29: Global Market for Wound Care Biologics for Venous Ulcers, by Region, Through 2030
Table 30: Global Market for Wound Care Biologics for Diabetic Foot Ulcers, by Region, Through 2030
Table 31: FDA-Approved Wound Care Biologics for DFU Treatment
Table 32: Wound Care Biologics in Clinical Trials for DFU Treatment
Table 33: Global Market for Wound Care Biologics for Pressure Ulcers, by Region, Through 2030
Table 34: Global Market for Wound Care Biologics for Arterial and Other Ulcers, by Region, Through 2030
Table 35: Global Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 36: Global Market for Wound Care Biologics for Acute Wounds, by Region, Through 2030
Table 37: Global Market for Wound Care Biologics for Surgical and Traumatic Wounds, by Region, Through 2030
Table 38: Burn Classifications
Table 39: Global Market for Wound Care Biologics for Burns, by Region, Through 2030
Table 40: Global Market for Wound Care Biologics, by End User, Through 2030
Table 41: Global Market for Wound Care Biologics for Ambulatory Surgery Centers, by Region, Through 2030
Table 42: Global Market for Wound Care Biologics for Hospitals, by Region, Through 2030
Table 43: Global Market for Wound Care Biologics for Burn Care Centers and Wound Clinics, by Region, Through 2030
Table 44: Global Market for Wound Care Biologics, by Region, Through 2030
Table 45: North American Market for Wound Care Biologics, by Product Type, Through 2030
Table 46: North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 47: North American Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 48: North American Market for Wound Care Biologics, by Application, Through 2030
Table 49: North American Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 50: North American Market for Wound Care Biologics for Acute Wounds, by Type Through 2030
Table 51: North American Market for Wound Care Biologics, by End User, Through 2030
Table 52: North American Market for Wound Care Biologics, by Country, Through 2030
Table 53: European Market for Wound Care Biologics, by Product Type, Through 2030
Table 54: European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 55: European Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 56: European Market for Wound Care Biologics, by Application, Through 2030
Table 57: European Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 58: European Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 59: European Market for Wound Care Biologics, by End User, Through 2030
Table 60: European Market for Wound Care Biologics, by Country, Through 2030
Table 61: Asia-Pacific Market for Wound Care Biologics, by Product Type, Through 2030
Table 62: Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 63: Asia-Pacific Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 64: Asia-Pacific Market for Wound Care Biologics, by Application, Through 2030
Table 65: Asia-Pacific Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 66: Asia-Pacific Market for Wound Care Biologics for Acute Wounds, by Type, Through 2030
Table 67: Asia-Pacific Market for Wound Care Biologics, by End User, Through 2030
Table 68: Asia-Pacific Market for Wound Care Biologics, by Country, Through 2030
Table 69: Rest of the World Market for Wound Care Biologics, by Product Type, Through 2030
Table 70: Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, Through 2030
Table 71: Rest of the World Market for Wound Care Biologics for Cellular and Tissue-Based Products, by Material, Through 2030
Table 72: Rest of the World Market for Wound Care Biologics, by Application, Through 2030
Table 73: Rest of the World Market for Wound Care Biologics for Chronic Wounds, by Type, Through 2030
Table 74: Rest of the World Market for Wound Care Biologics for Acute Wounds, by TypeThrough 2030
Table 75: Rest of the World Market for Wound Care Biologics, by End User, Through 2030
Table 76: Rest of the World Market for Wound Care Biologics, by Sub-Region, Through 2030
Table 77: Top Companies Ranking, 2024
Table 78: Key Wound Care Biologics Manufacturers’ Offerings
Table 79: Leading Companies in Allografts
Table 80: Key Companies’ Allograft Offerings, by Product Type
Table 81: Leading Acellular Animal-Derived Tissue-Based Products/Xenografts
Table 82: Recent Developments in the Wound Care Biologics Market, 2023-2025
Table 83: Abbreviations Used in This Report
Table 84: AbbVie Inc.: Company Snapshot
Table 85: AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 86: AbbVie Inc.: Product Portfolio
Table 87: AbbVie Inc.: News/Key Developments, 2023-2025
Table 88: Aroa Biosurgery Ltd.: Company Snapshot
Table 89: Aroa Biosurgery Ltd.: Financial Performance, FY 2023 and 2024
Table 90: Aroa Biosurgery Ltd.: Product Portfolio
Table 91: Aroa Biosurgery Ltd.: News/Key Developments, 2023-2024
Table 92: BioTissue: Company Snapshot
Table 93: BioTissue: Product Portfolio
Table 94: BioTissue: News/Key Developments, 2023-2025
Table 95: Bioventus: Company Snapshot
Table 96: Bioventus: Financial Performance, FY 2023 and 2024
Table 97: Bioventus: Product Portfolio
Table 98: Cellution Biologics Inc.: Company Snapshot
Table 99: Cellution Biologics Inc.: Product Portfolio
Table 100: Cellution Biologics Inc.: News/Key Developments, 2024-2025
Table 101: Convatec Group PLC: Company Snapshot
Table 102: Convatec Group PLC: Financial Performance, FY 2023 and 2024
Table 103: Convatec Group PLC: Product Portfolio
Table 104: Convatec Group PLC: News/Key Developments, 2025
Table 105: Elutia: Company Snapshot
Table 106: Elutia: Financial Performance, FY 2023 and 2024
Table 107: Elutia: Product Portfolio
Table 108: Elutia: News/Key Developments, 2024-2025
Table 109: Fibroheal: Company Snapshot
Table 110: Fibroheal: Product Portfolio
Table 111: Fibroheal: News/Key Developments, 2024
Table 112: Integra LifeSciences Corp.: Company Snapshot
Table 113: Integra LifeSciences Corp.: Financial Performance, FY 2023 and 2024
Table 114: Integra LifeSciences Corp.: Product Portfolio
Table 115: Integra LifeSciences Corp.: News/Key Developments, 2024
Table 116: Johnson & Johnson: Company Snapshot
Table 117: Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 118: Johnson & Johnson: Product Portfolio
Table 119: MIMEDX Group Inc.: Company Snapshot
Table 120: MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
Table 121: MIMEDX Group Inc.: Product Portfolio
Table 122: MIMEDX Group Inc.: News/Key Developments, 2022-2024
Table 123: Organogenesis Inc.: Company Snapshot
Table 124: Organogenesis Inc.: Financial Performance, FY 2023 and 2024
Table 125: Organogenesis Inc.: Product Portfolio
Table 126: Skye Biologics Holdings LLC.: Company Snapshot
Table 127: Skye Biologics Holdings LLC.: Product Portfolio
Table 128: Smith+Nephew: Company Snapshot
Table 129: Smith+Nephew: Financial Performance, FY 2023 and 2024
Table 130: Smith+Nephew: Product Portfolio
Table 131: Smith+Nephew: News/Key Developments, 2023-2024
Table 132: Stryker: Company Snapshot
Table 133: Stryker: Financial Performance, FY 2023 and 2024
Table 134: Stryker: Product Portfolio
Table 135: Stryker: News/Key Developments, 2025
Table 136: Zimmer Biomet: Company Snapshot
Table 137: Zimmer Biomet: Financial Performance, FY 2023 and 2024
Table 138: Zimmer Biomet: Product Portfolio
List of Figures
Summary Figure: Summary Figure: Global Market Shares of Wound Care Biologics, by Region, 2024
Figure 1: Stages of Wound Healing
Figure 2: PESTEL Analysis: Wound Care Biologics Market
Figure 3: Porter’s Five Forces Analysis of the Wound Care Biologics Market
Figure 4: Snapshot of the Market Dynamics for Wound Care Biologics
Figure 5: Estimated Number of People Aged 20 to 79 with Diabetes, Globally, 2000-2024
Figure 6: Emerging Technologies in Wound Care Biologics Market
Figure 7: Global Market Shares of Wound Care Biologics, by Product Type, 2024
Figure 8: Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Composition, 2024
Figure 9: Global Market Shares of Wound Care Biologics for Cellular and Tissue-Based Products, by Material, 2024
Figure 10: Global Market Shares of Biologic Skin Substitute, by Tissue Source, 2024
Figure 11: Global Market Shares of Wound Care Biologics for Bioengineered Skin Substitute, by Composition, 2024
Figure 12: Global Market Shares of Wound Care Biologics, by Application, 2024
Figure 13: Global Market Shares of Chronic Wounds, by Type, 2024
Figure 14: Global Market Shares of Acute Wounds, by Type, 2024
Figure 15: Global Market Shares of Wound Care Biologics, by End User, 2024
Figure 16: Global Market Shares of Wound Care Biologics, by Region, 2024
Figure 17: North American Market Shares of Wound Care Biologics, by Country, 2024
Figure 18: U.S. Elderly Population (65 and Older), 2010-2050
Figure 19: European Market Shares of Wound Care Biologics, by Country, 2024
Figure 20: Asia-Pacific Market Shares of Wound Care Biologics, by Country, 2024
Figure 21: Rest of the World Market Shares of Wound Care Biologics, by Sub-Region, 2024
Figure 22: AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 23: AbbVie Inc.: Revenue Shares, by Region/Country, FY 2024
Figure 24: Aroa Biosurgery Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 25: Aroa Biosurgery Ltd.: Revenue Shares, by Region/Country, FY 2024
Figure 26: Bioventus: Revenue Shares, by Region, FY 2024
Figure 27: Convatec Group PLC: Revenue Shares, by Business Unit, FY 2024
Figure 28: Convatec Group PLC: Revenue Shares, by Region, FY 2024
Figure 29: Elutia: Revenue Shares, by Business Unit, FY 2024
Figure 30: Integra LifeSciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 31: Integra LifeSciences Corp.: Revenue Shares, by Region, FY 2024
Figure 32: Johnson & Johnson: Revenue Shares, by Business Segment, FY 2024
Figure 33: Johnson & Johnson: Revenue Shares, by Country/Region, FY 2024
Figure 34: MIMEDX Group Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35: Organogenesis Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 36: Smith+Nephew: Revenue Shares, by Business Unit, FY 2024
Figure 37: Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
Figure 38: Stryker: Revenue Shares, by Business Unit, FY 2024
Figure 39: Stryker: Revenue Shares, by Country/Region, FY 2024
Figure 40: Zimmer Biomet: Revenue Shares, by Business Unit, FY 2024
Figure 41: Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024
